CNBC June 27, 2024
Annika Kim Constantino

Key Points

– Walgreens reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook due to a “challenging” environment for pharmacies and U.S. consumers.

– The company topped revenue estimates for the quarter on strong performance in its health-care segment.

– The results come as Walgreens works to slash costs by closing underperforming U.S. stores, among other efforts.

Shares of Walgreens plunged more than 20% on Thursday after the company reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook, citing a “challenging” environment for pharmacies and U.S. consumers.

The retail pharmacy giant now expects fiscal 2024 adjusted earnings of $2.80 to $2.95 per share. That compares...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Pharma, Pharma / Biotech, Provider, Retailer
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
Building for the Healthcare Consumer with Elliot Cohen
Fortune: The 61 most innovative companies in healthcare

Share This Article